5,140 Shares in Danaher Corporation $DHR Bought by Holcombe Financial Inc.

Holcombe Financial Inc. purchased a new position in Danaher Corporation (NYSE:DHR) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 5,140 shares of the conglomerate’s stock, valued at approximately $1,139,000. Danaher comprises 0.6% of Holcombe Financial Inc.’s holdings, making the stock its 19th biggest holding.

Other institutional investors also recently modified their holdings of the company. Veery Capital LLC raised its position in shares of Danaher by 3.1% during the third quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate’s stock worth $350,000 after purchasing an additional 48 shares during the period. Studio Investment Management LLC increased its stake in Danaher by 3.3% in the 2nd quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock worth $302,000 after purchasing an additional 51 shares in the last quarter. JDH Wealth Management LLC increased its stake in Danaher by 4.5% in the 1st quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate’s stock worth $240,000 after purchasing an additional 55 shares in the last quarter. OLD Second National Bank of Aurora raised its holdings in Danaher by 0.5% during the 1st quarter. OLD Second National Bank of Aurora now owns 12,114 shares of the conglomerate’s stock worth $2,297,000 after buying an additional 57 shares during the period. Finally, Adelphi Trust Co lifted its stake in Danaher by 2.5% during the third quarter. Adelphi Trust Co now owns 2,365 shares of the conglomerate’s stock valued at $524,000 after buying an additional 57 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 1.1%

Shares of DHR traded down $2.63 during trading hours on Friday, reaching $228.87. The company’s stock had a trading volume of 3,516,366 shares, compared to its average volume of 4,667,069. The firm has a market cap of $160.89 billion, a price-to-earnings ratio of 40.65, a P/E/G ratio of 2.91 and a beta of 0.76. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a 50 day moving average of $214.04 and a two-hundred day moving average of $195.97.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same period last year, the company posted $0.77 earnings per share. The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. As a group, research analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a $0.40 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s dividend payout ratio is presently 28.42%.

Analysts Set New Price Targets

Several research analysts have commented on DHR shares. Royal Bank Of Canada raised their target price on shares of Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a report on Monday, October 5th. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research report on Saturday, October 10th. Weiss Ratings raised shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, September 16th. UBS Group began coverage on shares of Danaher in a research report on Wednesday, September 9th. They set a “buy” rating and a $250.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $240.00 target price on shares of Danaher in a research note on Wednesday, July 22nd. Two analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $235.41.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.